Unified Medical Language System (UMLS). Medical Subject Headings (MeSH)

MeSH 2025
Enter one or more words or parts of words

Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 6-chloro-3,4-dihydro-3-((2-propenylthio)methyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide and (17alpha)-17-hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid monopotassium salt (MeSH)
Search & browse in old database

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 6-chloro-3,4-dihydro-3-((2-propenylthio)methyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide and (17alpha)-17-hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid monopotassium salt (MeSH) - C0051123
L0158899
S0217022
A0239272
M0049030
MeSH N1 C006445 doctor.am